What is PACS Group's earnings per share (EPS)?

PACS Group (PACS) reported diluted earnings per share of $1.22 for fiscal year 2025. This represents a 221.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

PACS Group Financials

PACS

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows PACS Group (PACS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 57/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

PACS Group has an operating margin of 5.9%, meaning the company retains $6 of operating profit per $100 of revenue. This results in a moderate score of 35/100, indicating healthy but not exceptional operating efficiency. This is up from 3.0% the prior year.

Growth

PACS Group's revenue surged 29.3% year-over-year to $5.3B, reflecting rapid business expansion. This strong growth earns a score of 82/100.

Leverage

PACS Group carries a low D/E ratio of 0.26, meaning only $0.26 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

PACS Group's current ratio of 1.07 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 16/100, which could limit financial flexibility.

Returns

PACS Group's ROE of 20.2% shows moderate profitability relative to equity, earning a score of 56/100. This is up from 7.9% the prior year.

Altman Z-Score Grey Zone

1.88

PACS Group scores 1.88, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Strong

8/9

PACS Group passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.11x

For every $1 of reported earnings, PACS Group generates $2.11 in operating cash flow ($404.2M OCF vs $191.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

10.9x

PACS Group earns $10.9 in operating income for every $1 of interest expense ($309.6M vs $28.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$5.3B

YoY+29.3%

PACS Group generated $5.3B in revenue in fiscal year 2025. This represents an increase of 29.3% from the prior year.

EBITDA

N/A

Net Income

$191.5M

YoY+243.5%

PACS Group reported $191.5M in net income in fiscal year 2025. This represents an increase of 243.5% from the prior year.

EPS (Diluted)

$1.22

YoY+221.1%

PACS Group earned $1.22 per diluted share (EPS) in fiscal year 2025. This represents an increase of 221.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$197.0M

YoY+25.0%

PACS Group held $197.0M in cash against $244.8M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

157M

YoY+0.9%

PACS Group had 157M shares outstanding in fiscal year 2025. This represents an increase of 0.9% from the prior year.

Margins & Returns

Gross Margin

21.9%

YoY+2.5pp

PACS Group's gross margin was 21.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.5 percentage points from the prior year.

Operating Margin

5.9%

YoY+2.8pp

PACS Group's operating margin was 5.9% in fiscal year 2025, reflecting core business profitability. This is up 2.8 percentage points from the prior year.

Net Margin

3.6%

YoY+2.3pp

PACS Group's net profit margin was 3.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.3 percentage points from the prior year.

Return on Equity

20.2%

YoY+12.4pp

PACS Group's ROE was 20.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 12.4 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

PACS Income Statement

Metric	FY25	FY24	FY23	FY22
Revenue	$5.3B+29.3%	$4.1B+31.4%	$3.1B+28.5%	$2.4B
Cost of Revenue	$4.1B+25.3%	$3.3B+34.7%	$2.4B+31.5%	$1.9B
Gross Profit	$1.2B+46.2%	$792.6M+19.4%	$663.8M+18.4%	$560.7M
R&D Expenses	N/A	N/A	N/A	N/A
SG&A Expenses	$415.1M+20.7%	$343.8M+60.9%	$213.7M+43.4%	$149.0M
Operating Income	$309.6M+151.6%	$123.1M-40.8%	$207.8M-9.4%	$229.4M
Interest Expense	$28.4M-36.0%	$44.3M-11.2%	$49.9M+95.5%	$25.5M
Income Tax	$93.0M+101.2%	$46.2M+4.0%	$44.4M-21.4%	$56.5M
Net Income	$191.5M+243.5%	$55.8M-50.6%	$112.9M-25.0%	$150.5M
EPS (Diluted)	$1.22+221.1%	$0.38-56.8%	$0.88-24.8%	$1.17

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$1.4B+1.0%	$1.3B+2.7%	$1.3B+2.5%	$1.3B+5.7%	$1.2B+17.7%	$1.0B+9.7%	$935.7M+1.7%	$919.8M
Cost of Revenue	$1.0B-0.7%	$1.0B+2.5%	$1.0B-0.3%	$1.0B+7.8%	$949.4M+11.7%	$849.6M+11.5%	$762.1M+3.6%	$736.0M
Gross Profit	$319.2M+7.0%	$298.3M+3.4%	$288.4M+13.8%	$253.4M-2.0%	$258.5M+46.3%	$176.7M+1.8%	$173.6M-5.6%	$183.8M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$113.5M+10.7%	$102.5M+2.2%	$100.3M+1.6%	$98.7M+10.1%	$89.6M+27.0%	$70.6M-48.4%	$136.7M+191.4%	$46.9M
Operating Income	$94.7M+9.8%	$86.3M+7.2%	$80.5M+67.2%	$48.1M-33.1%	$72.0M+213.4%	$23.0M+161.8%	-$37.2M-156.9%	$65.3M
Interest Expense	$8.6M+0.6%	$8.5M+95.9%	$4.4M-36.9%	$6.9M-25.8%	$9.3M+3.0%	$9.0M-8.9%	$9.9M-38.4%	$16.1M
Income Tax	$27.0M+12.8%	$24.0M-13.3%	$27.6M+92.7%	$14.3M-42.6%	$25.0M+43.3%	$17.4M+191.2%	-$19.1M-183.6%	$22.9M
Net Income	$59.7M+13.9%	$52.4M+2.8%	$51.0M+79.0%	$28.5M-23.5%	$37.2M+138.2%	$15.6M+149.0%	-$31.9M-191.6%	$34.8M
EPS (Diluted)	N/A	$0.32+3.2%	$0.31+82.4%	$0.17	N/A	$0.10+147.6%	$-0.21-177.8%	$0.27

PACS Balance Sheet

Metric	FY25	FY24	FY23	FY22
Total Assets	$5.6B+6.5%	$5.2B+49.3%	$3.5B	N/A
Current Assets	$1.1B+14.0%	$938.3M+29.9%	$722.1M	N/A
Cash & Equivalents	$197.0M+25.0%	$157.7M+114.8%	$73.4M+26.0%	$58.3M
Inventory	N/A	N/A	N/A	N/A
Accounts Receivable	$628.1M-2.1%	$641.8M+17.2%	$547.8M	N/A
Goodwill	$61.8M+1.6%	$60.8M+3.0%	$59.0M+6.9%	$55.2M
Total Liabilities	$4.6B+2.3%	$4.5B+32.7%	$3.4B	N/A
Current Liabilities	$1.0B+2.4%	$978.4M+114.1%	$456.9M	N/A
Long-Term Debt	$244.8M-2.5%	$251.0M+28.2%	$195.7M	N/A
Total Equity	$946.8M+33.4%	$709.6M+638.1%	$96.1M+40.0%	$68.7M
Retained Earnings	$309.6M+162.3%	$118.0M+23.0%	$96.0M	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$5.6B-0.8%	$5.6B+2.3%	$5.5B+0.1%	$5.5B+4.8%	$5.2B+16.1%	$4.5B+14.8%	$3.9B+1.9%	$3.9B
Current Assets	$1.1B-5.1%	$1.1B+4.6%	$1.1B-0.4%	$1.1B+15.3%	$938.3M+27.7%	$734.8M-3.8%	$763.7M-7.0%	$820.8M
Cash & Equivalents	$197.0M-44.6%	$355.7M+20.9%	$294.2M+2.3%	$287.5M+82.3%	$157.7M+218.4%	$49.5M-32.5%	$73.4M-9.7%	$81.2M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$628.1M0.0%	$628.3M-1.5%	$638.1M-6.3%	$680.7M+6.1%	$641.8M+11.7%	$574.6M-0.9%	$580.1M-5.2%	$611.8M
Goodwill	$61.8M	N/A	N/A	N/A	$60.8M	N/A	N/A	N/A
Total Liabilities	$4.6B-2.5%	$4.7B+1.3%	$4.7B-1.0%	$4.7B+4.7%	$4.5B+17.6%	$3.8B+13.6%	$3.4B-9.4%	$3.7B
Current Liabilities	$1.0B-16.4%	$1.2B+2.6%	$1.2B+5.4%	$1.1B+13.2%	$978.4M+43.5%	$681.7M+39.6%	$488.2M-8.8%	$535.4M
Long-Term Debt	$244.8M-0.4%	$245.9M-0.4%	$247.0M-0.8%	$249.1M-0.8%	$251.0M-1.0%	$253.6M+11.7%	$227.1M-1.6%	$230.9M
Total Equity	$946.8M+8.7%	$871.3M+8.0%	$806.8M+7.5%	$750.2M+5.7%	$709.6M+7.5%	$660.0M+23.0%	$536.8M+372.3%	$113.7M
Retained Earnings	$309.6M+23.9%	$249.9M+26.5%	$197.5M+34.8%	$146.5M+24.1%	$118.0M+46.0%	$80.8M+24.0%	$65.2M-42.5%	$113.3M

PACS Cash Flow Statement

Metric	FY25	FY24	FY23	FY22
Operating Cash Flow	$404.2M+10.0%	$367.3M+476.7%	$63.7M-31.2%	$92.6M
Capital Expenditures	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A
Investing Cash Flow	-$264.0M+40.4%	-$442.7M-156.2%	-$172.8M-129.4%	-$75.3M
Financing Cash Flow	-$69.0M-158.7%	$117.5M-9.3%	$129.6M+949.3%	$12.3M
Dividends Paid	$0-100.0%	$33.7M-58.1%	$80.4M+33.4%	$60.3M
Share Buybacks	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$3.4M-101.7%	$204.8M+289.5%	$52.6M-65.0%	$150.2M+132.6%	$64.6M-69.1%	$209.2M+501.7%	$34.8M-40.8%	$58.8M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$118.1M-21.7%	-$97.1M-199.5%	-$32.4M-97.4%	-$16.4M+84.3%	-$104.3M-5.7%	-$98.7M+18.4%	-$121.0M-1.9%	-$118.7M
Financing Cash Flow	-$5.5M+88.2%	-$46.3M-252.8%	-$13.1M-223.1%	-$4.1M-102.9%	$138.6M+209.7%	-$126.4M-278.5%	$70.8M+105.2%	$34.5M
Dividends Paid	$0	$0	$0	$0	$0	$0-100.0%	$16.2M-7.0%	$17.5M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

PACS Financial Ratios

Metric	FY25	FY24	FY23	FY22
Gross Margin	21.9%+2.5pp	19.4%-1.9pp	21.3%-1.8pp	23.2%
Operating Margin	5.9%+2.8pp	3.0%-3.7pp	6.7%-2.8pp	9.5%
Net Margin	3.6%+2.3pp	1.4%-2.3pp	3.6%-2.6pp	6.2%
Return on Equity	20.2%+12.4pp	7.9%-109.6pp	117.4%-101.8pp	219.2%
Return on Assets	3.4%+2.4pp	1.1%-2.1pp	3.2%	N/A
Current Ratio	1.07+0.1	0.96-0.6	1.58	N/A
Debt-to-Equity	0.26-0.1	0.35-1.7	2.04	N/A
FCF Margin	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	23.5%+1.3pp	22.2%+0.2pp	22.0%+2.2pp	19.8%-1.6pp	21.4%+4.2pp	17.2%-1.3pp	18.6%-1.4pp	20.0%
Operating Margin	7.0%+0.6pp	6.4%+0.3pp	6.2%+2.4pp	3.8%-2.2pp	6.0%+3.7pp	2.2%+6.2pp	-4.0%-11.1pp	7.1%
Net Margin	4.4%+0.5pp	3.9%+0.0pp	3.9%+1.7pp	2.2%-0.9pp	3.1%+1.6pp	1.5%+4.9pp	-3.4%-7.2pp	3.8%
Return on Equity	6.3%+0.3pp	6.0%-0.3pp	6.3%+2.5pp	3.8%-1.4pp	5.2%+2.9pp	2.4%+8.3pp	-5.9%-36.6pp	30.6%
Return on Assets	1.1%+0.1pp	0.9%0.0pp	0.9%+0.4pp	0.5%-0.2pp	0.7%+0.4pp	0.4%+1.2pp	-0.8%-1.7pp	0.9%
Current Ratio	1.07+0.1	0.94+0.0	0.92-0.1	0.98+0.0	0.96-0.1	1.08-0.5	1.56+0.0	1.53
Debt-to-Equity	0.26-0.0	0.28-0.0	0.31-0.0	0.33-0.0	0.35-0.0	0.38-0.0	0.42-1.6	2.03
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Select Medical SEM

$2.0B

National Health NHC

$2.5B

Ardent Health ARDT

$1.2B

Aveanna Healthcare Holdings, Inc. AVAH

$1.4B

Pediatrix Medical Group, Inc. MD

$1.8B

Frequently Asked Questions

What is PACS Group's annual revenue?

PACS Group (PACS) reported $5.3B in total revenue for fiscal year 2025. This represents a 29.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is PACS Group's revenue growing?

PACS Group (PACS) revenue grew by 29.3% year-over-year, from $4.1B to $5.3B in fiscal year 2025.

Is PACS Group profitable?

Yes, PACS Group (PACS) reported a net income of $191.5M in fiscal year 2025, with a net profit margin of 3.6%.

How much debt does PACS Group have?

As of fiscal year 2025, PACS Group (PACS) had $197.0M in cash and equivalents against $244.8M in long-term debt.

What is PACS Group's gross margin?

PACS Group (PACS) had a gross margin of 21.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is PACS Group's operating margin?

PACS Group (PACS) had an operating margin of 5.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is PACS Group's net profit margin?

PACS Group (PACS) had a net profit margin of 3.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is PACS Group's return on equity (ROE)?

PACS Group (PACS) has a return on equity of 20.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is PACS Group's operating cash flow?

PACS Group (PACS) generated $404.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are PACS Group's total assets?

PACS Group (PACS) had $5.6B in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does PACS Group have outstanding?

PACS Group (PACS) had 157M shares outstanding as of fiscal year 2025.

What is PACS Group's current ratio?

PACS Group (PACS) had a current ratio of 1.07 as of fiscal year 2025, which is considered adequate.

What is PACS Group's debt-to-equity ratio?

PACS Group (PACS) had a debt-to-equity ratio of 0.26 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is PACS Group's return on assets (ROA)?

PACS Group (PACS) had a return on assets of 3.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is PACS Group's Altman Z-Score?

PACS Group (PACS) has an Altman Z-Score of 1.88, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is PACS Group's Piotroski F-Score?

PACS Group (PACS) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are PACS Group's earnings high quality?

PACS Group (PACS) has an earnings quality ratio of 2.11x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can PACS Group cover its interest payments?

PACS Group (PACS) has an interest coverage ratio of 10.9x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is PACS Group?

PACS Group (PACS) scores 57 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.